From Critical Care Medicine.
The authors sought to determine the frequency of venous thromboembolism in critically ill coronavirus disease 2019 patients and associate a degree of inflammatory marker elevation to venous thromboembolism development. They found that routine chemical venous thromboembolism prophylaxis may be inadequate in preventing venous thromboembolism in severe coronavirus disease 2019.
Authors:
Thomas K. Maatman, MD
Farid Jalali, MD
Cyrus Feizpour, MD
Anthony Douglas, II BS
Sean P. McGuire, MD
Gabriel Kinnaman, BS
Jennifer L. Hartwell, MD
Benjamin T. Maatman, MD
Rolf P. Kreutz, MD
Rajat Kapoor, MD
Omar Rahman, MD
Nicholas J. Zyromski, MD
Ashley D. Meagher, MD, MPH
Estimated Time: 24:31 min